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Abstract In order to quantify the effect of polyethylene glycol 
4000 (PEG) on the solubility of an integral membrane protein, 
we have crystallized the photochemical reaction center from 
Rhodobacter sphaeroides Y by batch method on a large range of 
PEG. The measurement of the solubility diagram display a semi-
logarithmic dependence of solubility versus PEG concentration. 
Comparison of our results with previously published ones 
[Odahara, T., Ataka, M. and Katsura, M. (1994) Acta Cryst. 
D50, 639-642] suggests a notable effect of additional 1,2,3-
heptane-triol and/or temperature on photochemical reaction 
center solubility. 
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1. Introduction 
Solubility of a protein is an important thermodynamic 
parameter which reflects intermolecular interactions occurring 
between the macromolecules and the solvent constituents [1]. 
Solubility (S) refers to the concentration of soluble protein in 
equilibrium with crystallized protein at given values of pH, 
temperature and solvent components. Over the last decade, 
about 30 measurements for soluble proteins allowed to better 
appreciate effects of crystallization parameters. 
Until 1980, it was considered as unlikely that membrane 
protein could crystallized; however, successful crystallizations 
opened the way [2,3]. Nevertheless progress in crystallization 
of membrane proteins was slow and the 3D structure deter-
minations of membrane proteins are still rare [4-13]. The nu-
merous difficulties in crystallization of membrane protein have 
encouraged crystallogenesis studies on this topic, especially on 
detergents effects. However solubility data for membrane pro-
teins were lacking until recently [14]; furthermore the amphi-
philic nature of these proteins, the necessity of detergent for 
their solubilization and for the crystallization might compli-
cate the analysis of their solubility diagrams. 
Most integral membrane proteins isolated in detergent so-
lution can be roughly described as composed of a hydropho-
bic core surrounded by a detergent ring, flanked by two hy-
drophilic regions devoid of detergent. Both the solubility of 
the protein and the micellar properties of the detergent are 
affected by the crystallization parameters. Above the solubility 
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Abbreviations: RC, photochemical reaction center; ß-OG, ß-D-octyl-
glucoside; LDAO, lauryldimethylamine N-oxide; Rb., Rhodobacter; 
PEG, polyethylene glycol 4000; C, conductivity; «D 1 8 C , refractive 
index at 18°C 
curve, aggregation of the protein is energetically favored. In 
the same way, aggregation of detergent micelles occurs above 
the consolution boundary, leading to phase separation and 
partition of the membrane protein in the detergent-rich phase 
[15-17]. Nevertheless, crystallization may occur as well after 
phase separation, as in its absence. The knowledge of solubil-
ity diagrams of membrane proteins is a prerequisite to quan-
tify how various parameters influence their crystallization. 
In this study the solubility was measured for Rb. sphae-
roides Y RC. This pigment-protein complex performs the in-
itial step of energy conversion, a light-induced transmembrane 
charge separation. It consists of three polypeptides L (281 
amino acids), M (307 amino acids) and H (260 amino acids) 
and several pigments and cofactors associated with L and M 
(total molecular mass 96300 Da). It was crystallized in an 
orthorhombic form using ß-OG as detergent, PEG 4000 and 
NaCl as crystallizing agents [18]. The X-ray structure has been 
determined at 3 A resolution [11]. Studies by neutron crystal-
lography [19] showed that in these crystals the order of mag-
nitude of the volumic fraction of ß-OG is 0.4. 
Here we report the solubility for Rb. sphaeroides Y RC, 
solubilized with ß-OG, as a function of PEG (the crystallizing 
agent) whereas all other parameters (temperature, detergent in 
solution and salt concentrations) are kept constant. The re-
sults are compared with the solubility diagram [14] obtained 
for RC also crystallized in the orthorhombic form with PEG, 
but at a different temperature and in the presence of 1,2,3-
heptane-triol, an additive commonly used for crystallizing 
membrane proteins [20]. 
2. Materials and methods 
2.1. Chemicals and materials 
The chemicals were purchased from indicated source: EDTA (Sig-
ma), LDAO (Fluka), ß-OG (Bachern), PEG (Merck, purified accord-
ing to [21]), NaN3, NaCl and Tris (Merck). 
The purity and concentration of RC solution were checked by 
measuring the absorbance at 280 nm and 802 nm with a Cary 2300 
spectrophotometer in 100-1000 μΐ quartz cells (Hellma). The absorp-
tion coefficient of native RC at 802 nm is 288 ± 14 mM -1 cm-1 [22] 
and the ratio A280nm/A802nm is expected to be equal to 1.2. The con-
ductivity and the refractive index were measured at 18°C with a radio-
meter conductivimeter and a refractometer, respectively. 
2.2. RC preparation 
The RC sample (~ 50 mg protein) was isolated and purified from 
Rb. sphaeroides membranes in presence of LDAO according to a 
procedure previously described [23,24]. This detergent was then ex-
changed for ß-OG: the protein sample was adsorbed on a 3 ml 
DEAE-Sepharose (Pharmacia) mini-column equilibrated with TEA/ 
ß-OG buffer solution (15 mM Tris-HCl, pH 8.0, 1 mM EDTA, 
0.1% (w/v) NaN3, 8 mg/ml ß-OG), washed with 30 ml of the same 
solution and the RC was eluted by 1 M NaCl TEA/ß-OG buffer. A 
Sephadex G25-column (PD10 Pharmacia), previously equilibrated 
with TEA/ß-OG buffer, was then used to remove NaCl. The protein 
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was finally concentrated by Ultrafiltration (Amicon membranes) to 
about 30 mg/ml and stored at 5°C in TEA/ß-OG. 
2.3. Crystallization methods and solubility measurements 
Preliminary experiments set to screen RC crystallization when vary-
ing either PEG or NaCl concentration were done by microdialysis as 
already described [25]. 
Determination of solubility was done by the batch method [26]. A 
protein solution and a PEG solution were mixed at concentrations for 
which crystallization was expected to occur. For these experiments, 
three stock solutions were prepared in volumetric flasks, and charac-
terized by their conductivity C and refractive index nD at 18°C: (1) 
TEA/ß-OG buffer, pH = 7.9 (see above): nD
18°c = 1.3360, C=1.6 
mOhm"1 cm"1; (2) 30% (w/v) PEG in TEA/ß-OG buffer, pH = 7.9: 
nO
18°c = 1.3760, C = 0.63 mOhm1 cm"1; and (3) 4.4 M NaCl in TEA/ 
ß-OG buffer, pH = 8.0: «D
18°c = 1.3750, C = 120 mOhnr1 cm"1. Ali-
quots of these solutions were mixed in transparent plastic vials (All-
tech) closed by water-tight silicon caps. Then the protein solution was 
added to this crystallizing solution (final volume of 30 μΐ or 50 μΐ) and 
mixed by Vortex. The vials were stored in a thermo-regulated cham-
ber at 18°C and in the dark. Considering the volume of aliquots («10 
μΐ) pipetted off the crystallization solution, and the reliability of the 
measurement (Hamilton syringes), the relative precision of initial con-
centrations was estimated as ± 2% for PEG and NaCl, and as ± 4% 
for RC. 
Because of the large number of experiments and the choice of using 
RC purified from a single batch, the crystallization experiments had to 
be prepared with different volumes: for experiments at 6.5-7.5% (w/v) 
PEG, high initial protein concentrations were required and 30 μΐ 
aliquots were sufficient to measure the final protein concentration; 
for experiments at 8.1% (w/v) PEG and above, the initial protein 
concentrations were lower and 50 μΐ aliquots were necessary. 
The solubility measurements were performed about 9 weeks after 
crystallization had started. Samples which had not crystallized or 
which presented either phase separation or protein precipitate were 
not taken into account. In the other ones, after centrifugation of the 
vials (1200Xg, 5 min) the supernatant was filtered (Millipore Millex 
GV4 filters) to remove possible microcrystals, and its absorbance was 
measured at 802 nm for measuring the residual soluble protein con-
centration. 
3. Results 
3.1. Preliminary determination of the crystallization conditions 
At the beginning of the study, conditions for obtaining X-
ray quality crystals of the RC were already known. Starting 
from these conditions of crystallization (micro-dialysis of a 2 
mg/ml protein solution against 10-14% (w/v) PEG, 220 mM 
NaCl and 8 mg/ml ß-OG at 18°C [25]), a first series of micro-
dialysis experiments were set to screen RC crystallization 
when varying either NaCl or PEG concentration. Although 
salts greatly change the physico-chemical properties of deter-
gent and may act on membrane protein crystallization [27], 
crystallization was rather independent on NaCl concentration 
in the range 0.1-0.3 M NaCl; however, it did not occur for 
higher values of NaCl concentration (when PEG was kept at 
10%, w/v). On the other hand, RC concentration for which 
crystallization occurred was strongly dependent on PEG final 
concentration (when 0.22 M NaCl was present). Consequently 
we chose to study RC solubility versus PEG concentration, 
keeping constant the other parameters: temperature (18°C), 
NaCl and ß-OG concentrations in the buffer (0.22 M and 8 
mg/ml, respectively). 
For solubility determination, crystallization was carried out 
using the batch technique (see Section 2). Contrary to vapor 
diffusion or dialysis which involve an equilibration between 
the protein solution and a reservoir, the batch technique pre-
sents the advantage of an accurate knowledge of the composi-
tion of the solution. Prior to the solubility diagram determi-
nation, crystallization conditions were established in a large 
range of PEG (4 to 14% (w/v)) and of protein (1-30 mg/ml) 
concentrations as shown in Table 1. Crystals were monocrys-
talline prisms at high PEG concentrations or bush-like at low-
er PEG concentration. Their morphology was similar to the 
one observed by micro-dialysis method. 
At 6.5 and 7.0% (w/v) PEG, crystallization was observed 
for the highest RC concentrations; it was less reproducible 
than for higher PEG concentrations, for which RC crystal-
lization occurred in most trials. At 12 and 14% (w/v) PEG and 
for the highest RC concentrations, a phase separation ap-
peared as a coexistence of brown droplets within a colorless 
solution. This phenomenon of phase separation has been pre-
viously described for RC [25] and also for other membrane 
proteins [28]. It was avoided in later experiments by lowering 
RC concentration. 
3.2. Equilibration kinetics 
Crystals generally appear faster using the batch method 
than the dialysis one because supersaturation is reached im-
mediately and not after equilibration of the solutions through 
the membrane. Indeed, crystallization occurred within 8 days 
Table 1 
Crystallization conditions used to determine the solubility of RC (in the presence of 220 mM NaCl), final concentrations of soluble protein and 
estimated supersaturations 
PEG 
concentration 
(%w/v) 
6.5 ±0.1 
6.75±0.1 
7.0 ±0.1 
7.5 ±0.1 
8.1 ±0.1 
9.0 ±0.1 
9.9 ±0.1 
12.0 ±0.2 
14.1 ±0.2 
Sample 
volume 
(μΐ) 
30 
30 
30 
30 
50 
50 
50 
50 
50 
RC concentration (mg/ml) 
Initial 
42.3/35.9/31.2a 
35.6/31.2/24.5a 
26.7/22.4/18.4" 
24.5/18.4/14.3a 
13.5/11.0/ 9.2a 
8.6/ 7.4/ 6.0 
7.4/ 6.1/ 5.4 
4.4/ 3.3/ 2.1 
3.7b/ 2.7/ 1.5 
Final 
12.8 ±0.4 
s=14.5 
9.4 ±0.2 
==10.1 
a 6.5 
2.6 ±0.2 
1.28±0.14 
0.25 ±0.04 
0.09 ±0.01 
Solubility 
(number of tests used for 
solubility determination) 
12.8 ±0.4 (5) 
(0) 
9.4 ±0.2 (3) 
(0) 
(0) 
2.6 ±0.2 (2) 
1.28 ±0.14 (4) 
0.25 ±0.04 (3) 
0.09 ±0.01 (5) 
Estimation of initial 
supersaturation 
3.3/ 2.8/ 2.4a 
3.3<7 2.9C/ 2.3C 
2.8V 2.4C/ 2.0ac 
3.8<7 2.8<7 2.2ac 
3.0V 2.4C/ 2.0ac 
3.3/ 2.8/ 2.3 
5.8/ 4.8/ 4.2 
17.6/13.2/ 8.4 
38.5b/28.1/17.6 
Underlined values indicate conditions for which precipitations, often in the presence of crystals, were observed after 9 weeks and which were not 
taken into account for the solubility calculation because the final RC concentration was then an overestimation of solubility. 
aEach trial having not crystallized. 
bPhase separation. 
cSupersaturation calculated with interpolated values of solubility. 
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in all trials, and often within 1 day, whereas crystals were 
obtained by the dialysis method after a few weeks [25]. Fig. 
1 shows that, after nucleation, soluble protein concentrations 
decreased quickly. After 3 weeks, protein concentrations re-
mained already constant indicating that the equilibrium was 
reached. This is noticeably faster than for soluble proteins 
[29]. For each PEG concentration, it was checked that solu-
tions of different initial RC concentrations had evolved to the 
same final concentration of soluble protein. Measurement of 
the solubility was thus performed about 9 weeks after the 
beginning of crystallization. 
3.3. Phase diagram and initial supersaturation 
A set of 49 experiments, differing by PEG and/or protein 
concentrations, was used to establish the phase diagram (Ta-
ble 1). Among them, 22 fulfilled the required conditions and 
were retained to determine the solubility values. Several sam-
ples at 6.75, 7.5 and 8.1% (w/v) PEG were discarded because 
they had not reached equilibrium. This seemed to be due to 
crystals coexisting with some precipitated protein. 
As shown in Fig. 2, the solubility fits with a logarithmic 
variation as a function of PEG concentration, within the 
range of tested conditions: 
logS = 3.0-0.29 [PEG] 
where S is the solubility of the RC (mg/ml) and [PEG] the 
PEG concentration (% w/v). The correlation coefficient of this 
empirical function is 0.998. 
Once this solubility curve was known, it was possible to 
calculate the initial supersaturation a posteriori in the various 
samples, by dividing their initial RC concentration by the 
solubility value measured at their PEG concentration (Table 
1). The solubility curve was necessary in particular to calcu-
late the supersaturation of the samples for which precipitation 
were observed (e.g. 6.75, 7.5 and 8.1% PEG). We observed 
that the minimal supersaturation for which crystals grew was 
in the range 2.3-2.9. On the other hand, for supersaturation 
higher than 30, phase separation was often observed. 
4. Discussion 
We succeeded in crystallizing Rb. sphaeroides RC in a range 
of PEG for which the solubility of the RC varied by two 
orders of magnitude, and on a range of supersaturation vary-
ing from 2 to 40. Exploring such a wide range of supersatura-
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Fig. 1. Kinetics of equilibration. 
Fig. 2. Phase diagrams of RC in presence of 8 mg/ml ß-OG and 
0.22 M NaCl in TEA buffer (plain line, this work), and in identical 
conditions except for the presence of 1% (w/v) 1,2,3 heptane-triol 
(dotted line, data replotted from [14]). 
tion and precipitant concentrations might be useful when op-
timizing crystallization conditions. 
A logarithmic dependence of the solubility of the protein/ 
detergent complex versus PEG concentration was observed. 
This variation bears a formal resemblance with that observed 
for a number of soluble proteins in presence of salts (in the so-
called 'salting out' region) [30]. However, the underlying 
mechanisms are probably different because of the absence of 
electrostatic effects with PEG; they are also less documented 
for PEG than for salts [1]. A similar dependence of protein 
solubility versus PEG has been reported for some soluble 
proteins, although in that case protein concentration of super-
natant was measured after precipitation (and not crystalliza-
tion) [31]. For a membrane protein which is partly shielded 
from the aqueous solvent by its bound detergent, crystalliza-
tion is governed by the interactions of both protein and de-
tergent interfaces with solvent. Interactions at the hydrophilic 
surfaces of the membrane protein might be modified by PEG 
in the same way as for soluble proteins. Interactions at the 
interfaces between protein-bound detergent and solvent and 
their modifications by PEG are still not clear. It is known 
from the phase diagram of ß-octylglucoside in pure water or 
in presence of NaCl [32,33] that PEG lowers the consolution 
boundary between the micellar solution and the two-phase 
domain; a similar event can be expected in more complex 
micellar solutions containing membrane proteins. Such an ef-
fect of PEG might play a role in promoting nucleation; in-
deed approaching the consolution boundary has been shown 
to promote crystallization of several membrane proteins [33]. 
The RC solubility determined in this work is significantly 
different from results previously published by Odahara et al. 
[14] for the same protein. These authors used a batch method 
under conditions similar to our experiments, except for the 
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presence of a small amphiphile (1% (w/v) 1,2,3-heptane-triol) 
and for the temperature (25°C). Some of the protein precipi-
tated right after mixing the batch components and was elimi-
nated before crystallization could proceed. In our case, such a 
precipitation was not observed in most samples and when it 
occurred, these samples were not used. However, both solu-
bility curves follow a logarithmic variation versus PEG con-
centration but do not have the same slope and differ in the 
PEG and protein ranges (see Fig. 2). In particular no crystal-
lization was observed by Odahara et al. at PEG concentra-
tions lower than 14% (w/v). Such a shift of the solubility 
curves can be related to the difference of temperature and/or 
to the presence of 1,2,3-heptane-triol. Both parameters may 
affect the solubility of RC as well as the consolution boundary 
of the detergent. The small amphiphile has been introduced as 
a crystallization 'additive' (usually present at a quite high 
concentration) for a number of membrane protein crystalliza-
tion [15]. It was shown to modify size and shape of the mi-
celles of another non-ionic detergent, LDAO, in aqueous so-
lution [34] and to shift the consolution boundary of this 
detergent in presence of PEG [35]. Similarly the phase dia-
gram of ß-octylglucoside presents a temperature dependant 
consolution boundary when PEG is added [36]. Unfortunately 
no experimental data exist on the phase diagram of the ß-
octylglucoside/PEG/heptane-triol/temperature system to assess 
the contribution of the two latter parameters. 
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